Danny Yeung

Since 2014, Danny Yeung has been transforming healthcare with Prenetics, one of the world’s largest genetic testing companies, which has since pivoted to the vital work of producing Covid-19 testing kits. From the US, he started working as a telemarketer aged 15, but his first foray into entrepreneurship was franchising Hong Kong dessert chain Hui Lau Shan in the US, after which he ran a hospitality furniture company in Macau. He then founded group buying website Ubuyibuy, only to sell it to Groupon after just six months.

Prenetics has been his biggest success thus far. First, it launched CircleDNA, which sells affordable at-home test kits that detect disease risk, food sensitivities, personality and behavioural traits, allowing people to take their health into their own hands. Then, in April 2020, it rolled out Project Screen by Circle, a cheap Covid test that produces results in 16 to 24 hours, following it up with an RT-Lamp test that returns results in less than an hour, and that was famously adopted in football’s English Premier League. The company has been a financial high-flyer from the outset, and became Hong Kong’s first listed unicorn when it debuted on Nasdaq in 2022.

In 2023, he launched Insighta, a joint venture with scientist Dennis Lo. Insighta, which aims to revolutionise early detection of multi-cancer, is backed by US$100 million funding [more than HK$780 million] from Prenetics. Insighta plans to introduce Presight for screening lung and liver cancers in 2025, and to expand with Presight One for detecting more than ten cancers in 2027, bolstering Hong Kong’s standing as a global hub for life science innovations.

In 2024, the company received a US$30 million investment from Tencent into Insighta. Yeung also announced a partnership between Prenetics and football legend, entrepreneur and philanthropist David Beckham. Prenetics and Beckham will be co-founding partners of IM8, a health and wellness brand, which will offer cutting-edge health products.